MIST
Milestone Pharmaceuticals Inc
0.8097$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +219.2% | +40.1% | +21.5% | -20.1% | -37.9% | +1.0% | +0.4% | +50.4% | |
| – | +219.5% | +39.1% | +21.4% | -20.0% | -39.6% | +1.7% | +1.2% | +51.4% | |
| – | +690.0% | +39.4% | -39.7% | +57.8% | -93.3% | +80.2% | +84.0% | +188.6% | |
| – | +219.5% | +39.4% | +18.8% | -19.8% | -43.4% | +2.2% | +5.6% | +52.0% | |
| – | +24.7% | +23.5% | +13.4% | -49.1% | +151.1% | +217.5% | -37.9% | +46.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | -14.3% | +2,996.7% | +38.6% | -83.3% | +1,146.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +136.0% | -94.1% | -19.5% | +5.7% | +12.2% | +618.6% | +6.7% | +15.1% | |
| – | +182.4% | +83.7% | -26.0% | +10.0% | -9.4% | +17.7% | +12.5% | +72.0% | |
| – | – | – | -25.8% | -8.6% | +121.0% | +10.3% | +4.6% | +13.3% | |
| – | +64,975.0% | +68.1% | +6.1% | -5.5% | -48.4% | +75.9% | -51.5% | +192.2% | |
| – | – | – | – | – | – | – | +7.2% | +7.2% | |
| – | – | – | +24.5% | -21.3% | -41.1% | -74.7% | -21.6% | +217.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -33.3% | +85.9% | +42.6% | +1.5% | +1.2% | +44.8% | +34.8% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.